Altre lingue Windlas Biotech Limited

Azioni

WINDLAS

INE0H5O01029

Tempo differito NSE India S.E. Altri mercati azionari 09:11:35 09/07/2024			Variaz. 5gg	Var. 1 gen.
722,6 ^INR	+0,83%		-2,25%	+68,50%

20/05	Windlas Biotech Limited riporta i risultati degli utili per il quarto trimestre conclusosi il 31 marzo 2024	CI
20/05	Windlas Biotech Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	20/05
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	20/05
Windlas Biotech Commissions New Injectible Manufacturing Unit	02/04
Windlas Biotech Limited Commissions Its Injectable Facility	02/04
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Windlas Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11
Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23	12/09/23
Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2022-23	18/08/23
Windlas Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/08/23
Windlas Biotech's Consolidated Profit Slips in Fiscal Q4	08/05/23
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05/05/23
Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	05/05/23
Windlas Biotech Limited Recommends Dividend	05/05/23
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	05/05/23
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	03/05/23
Windlas Biotech Limited's Equity Buyback announced on November 8, 2022 has closed with 867,747 shares, representing 3.98% for INR 217.97 million.	03/05/23
Windlas Biotech's Consolidated Profit Climbs in Fiscal Q3	09/02/23
Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer	09/02/23
Windlas Biotech Appoints CEO	09/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Windlas Biotech Limited

Azioni

WINDLAS

INE0H5O01029

Altre lingue

Filtri